Navigation Links
Population Council presents new research at the International Conference on Family Planning
Date:11/15/2013

ntries, identify successful characteristics of contraceptive use, help inform governments interested in launching or expanding voucher programs, and recommend focused program designs to achieve supply and demand goals.

  • Key features include effective and inexpensive poverty-based targeting of demand subsidies, prompt and efficient payment to contracted providers, and transparent information systems to facilitate performance monitoring and service verification.

  • Researchers concluded that scaling up voucher programs requires keeping management costs low, maintaining quality of care, focusing on effective targeting, and coordinating family planning voucher subsidies through multiple service delivery channels to meet demand.

    "Results from our research indicate that family planning vouchers can improve equity by effectively reaching poor populations who want but cannot afford their preferred method without a subsidy," said Ben Bellows, Ph.D., Associate, Population Council.

    Oral Presentation: "The Effect of a Voucher Program on the Uptake of Long-Acting and Permanent Methods of Contraception in Kenya" (Ben Bellows, Associate, Population Council on behalf of Sam Wangila Wafula, lead author and former Bixby post-doctoral fellow at the Population Council, Kenya)

    While long-acting and permanent methods (LAPMs) (e.g., intrauterine devices, implants, and sterilization) can help women avoid unintended pregnancies, existing research showed that only 8.3 percent of Kenyan women of reproductive age were using LAPMs by 2009. Though government health facilities widely offer short-term contraceptives, use of LAPMs is very low given high out-of-pocket costs and limited provider knowledge about insertion.

  • A Council study sought to determine whether vouchers could increase use of LAPMs in Kenya. Following a survey of nearly 3,000 women ages 15-49 years, researchers evaluated the effect of a government-institut
    '/>"/>

  • Contact: Sasha Gruber
    sgruber@popcouncil.org
    760-351-6420
    Population Council
    Source:Eurekalert

    Page: 1 2 3 4 5 6 7 8

    Related medicine news :

    1. Exercise training is effective as prehabilitation before surgery in an elderly population
    2. Population Council awarded flagship family planning implementation science project by USAID
    3. Aging expert Colin Milner addresses United Nations' findings by offering "Nine Principles" for improving society's response to population aging
    4. Explorys Ranked As Top Market Leader in Chilmark 2013 Clinical Analytics for Population Health Market Trends Report
    5. Doomsday Preppers Find Protection in Secret-Room Business: Covert Concepts Offers Unique Service to the Growing Niche Population
    6. New CEO Tom Zajac to Lead Wellcentive through Explosive Growth in Population Health Market
    7. More than one-third of populations worldwide may have low levels of vitamin D, study shows
    8. SeniorQuote Expands Rapidly to Serve Growing Senior Population
    9. Prisons must do more to provide health and social care to growing population of older prisoners
    10. Commonly used catheters safety tied to patient population
    11. New poll shows minority populations support clinical trials to improve health of others
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:4/18/2014)... turns 160 years of neuroanatomy on its head. , ... essential for the fast transmission of impulses along the ... thought, according to a new work lead by Professor ... and the University,s Department of Stem Cell and Regenerative ... Department of Molecular and Cellular Biology. , "Myelin is ...
    (Date:4/18/2014)... April 18, 2014) Benaroya Research Institute at Virginia ... blocking a particular molecule in metastatic breast cancer reduces ... of lung metastases. BRI scientists have found in models ... tumors by 60 - 80 percent and can keep ... The $1.8 million five-year grant comes from the National ...
    (Date:4/18/2014)... . A ... A team led by Ludwik Leibler from the Laboratoire ... Letourneur from the Laboratoire Recherche Vasculaire Translationnelle (INSERM/Universits Paris ... principle of adhesion by aqueous solutions of nanoparticles can ... tissues. This easy-to-use gluing method has been tested on ...
    (Date:4/17/2014)... in non-cancerous prostate tissue may have nearly twice the ... no inflammation, according to results of a new study ... Center. , The link between persistent inflammation and cancer ... cancer those with a Gleason score between 7 ... aggressive and rapidly growing prostate cancers. , "What we,ve ...
    (Date:4/17/2014)... of the most popular vaccine brands for children may ... be overlooking some cost factors when choosing vaccines, driving ... option, according to a new study by University of ... can be driven by numerous factors," says Sheldon H. ... of computer science and of mathematics at the U. ...
    Breaking Medicine News(10 mins):Health News:Finding turns neuroanatomy on its head 2Health News:Finding turns neuroanatomy on its head 3Health News:Benaroya Research Institute evaluates immunology approach to blocking breast cancer 2Health News:Innovative strategy to facilitate organ repair 2Health News:Innovative strategy to facilitate organ repair 3Health News:Chronic inflammation linked to 'high-grade' prostate cancer 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 3Health News:Study recalculates costs of combination vaccines 2
    ... pink race gear on e Bay in favor of Susan ... Awareness month and pink is// the symbolic color of Breast ... Racing to create exclusive warriors in pink livery with exclusive ... the eBay auction. ,Parts of the Warrior in ...
    ... a team of researchers from the Edinburgh University, the risk ... a variant of a gene called// neuregulin. ,This ... high risk of developing schizophrenia were monitored for 10 years ... the volunteers had 2 or more relatives affected by this ...
    ... packets of counterfeit condoms of Durex best-selling 'extra safe' range ... ,A Durex spokeswoman stated that the company could not 'guarantee ... that were on sale in UK was also unknown,These counterfeits ... When tests were conducted at the company's laboratories it was ...
    ... which could protect children from meningococcal disease is being ... disease has not been// available. ,The researchers, ... Child Health Research and Princess Margaret Hospital for Children, ... meningococcal B strain which is the most common. It is ...
    ... Monday called for fast tracking of the approval ... effective against extremely drug resistant// tuberculosis(XDR-TB) which is ... ,MSF otherwise called Doctors Without Borders(DWB) has ... Food and Drug Administraton(USFDA) and European Medicines Agency ...
    ... must have spice in every Indian home now finds itself ... uses to fight// many tubborn inflammations and degenerative disorders thus ... scripts of Ayurveda. ,According to a recent study ... Janet L. Funk, MD, working with Barbara N. Timmermann, PhD ...
    Cached Medicine News:Health News:Gene Variant associated with Schizophrenia identified 2Health News:Faster Approval Procedures Urged For New TB Drugs 2
    (Date:1/15/2014)... Tegra Medical is very pleased to announce the appointment ... Chief Executive Officer.  Mark was promoted from his current role ... company,s four facilities in Massachusetts , ... Tegra Medical in 2012 with 20+ years of broad-based operations, ...
    (Date:1/15/2014)... PHILADELPHIA , Jan. 15, 2014  Echo Therapeutics, Inc. ... company developing its Symphony® CGM System as a non-invasive, ... Robert F. Doman , Executive Chairman and Interim CEO ... Capital Markets, Tenth Annual Equity Conference. ...
    (Date:1/15/2014)... 15, 2014  According to Millennium Research Group (MRG), ... the United States and ... will expand moderately through 2022, with embolization particles ... increasing interest in drug-eluting beads (DEBs) and radioembolization ...
    Breaking Medicine Technology:Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3
    ... found, results showed CYPHER(R) Stent ... had lower mortality and heart attack rates, ... patient data from a two-year randomized controlled trial comparing,the ... no,statistically significant differences in safety outcomes between the two,drug- ...
    ... Clinical investigators at the,European Society of Cardiology Congress ... Coronary Stent continued to,provide clinical benefits compared to a ... years of follow-up with no differences in safety. ... arm of the,study continued to be significantly less likely ...
    Cached Medicine Technology:Two-Year Outcomes From Large Head-to-Head Clinical Trial Indicate Similar Safety Profile in Diabetic Patients for Cypher(R) Sirolimus-Eluting Coronary Stent and Taxus Stent 2Two-Year Outcomes From Large Head-to-Head Clinical Trial Indicate Similar Safety Profile in Diabetic Patients for Cypher(R) Sirolimus-Eluting Coronary Stent and Taxus Stent 3Two-Year Outcomes From Large Head-to-Head Clinical Trial Indicate Similar Safety Profile in Diabetic Patients for Cypher(R) Sirolimus-Eluting Coronary Stent and Taxus Stent 4Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety 2Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety 3Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety 4Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety 5
    ... product line has the right product for ... and from intubated patients to patients with ... both anesthesia and critical care applications., ... protection for patients and staff members. This ...
    Passive heat and moisture exchangers for respiratory applications....
    Passive heat and moisture exchangers for respiratory applications....
    Ballard trach care HMES and filters, tv 500, HME...
    Medicine Products: